Company / SG&A per Share
ARS Pharmaceuticals, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.35
FY2025
5-year range
$0.15 / $2.35
FY2021-FY2025
Trend
+216.0%
vs FY2024
Sector context
#75 of 210
Health Care
What the data says
SG&A per Share changed +216% YoY in FY2025, a notable deviation from the 5-year average annual change of +78%.
Based on SEC 10-K filings.
2.35 in FY2025 with a 5-year CAGR of -3.9%.
Increased from $0.50 to $2.35 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +147.8%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
#136 of 210 in Health CareTop 64% of 210This company $2.35 Sector average $40.75
▼
-94.2% below sector average
Key checks
Key Insights
- ARS Pharmaceuticals, Inc.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 216.0% year-over-year.
- Ranks #75 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.35 | +216.0% |
| FY2024 | $0.74 | +47.7% |
| FY2023 | $0.50 | +226.1% |
| FY2022 | $0.15 | -4.9% |
| FY2021 | $0.16 | -94.3% |
| FY2020 | $2.87 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026